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Abstract: 
 
Purpose: 
Concern of anatomical anomalies and worsening neurologic symptoms has 
prevented widespread use of epidural catheters in patients with low level 
spina bifida (LLSB). We hypothesize that thoracic epidural placement in the 
T9-T10 interspace is safe and decreases narcotic requirements in LLSB 
patients following major open lower urinary tract reconstruction (LUTR).   
 
Materials and Methods:  
We reviewed consecutive LLSB patients who had LUTR and epidurals for 
post-operative pain control. Controls were LLSB patients who received 
single shot transversus abdominis plane (TAP) blocks with similar 
procedures. Complications from epidural placement, including changes in 
motor and sensory status were recorded. Opioid consumption was 
calculated utilizing equivalent IV morphine doses. Mean and maximum pain 
scores on post-operative day (POD) 0-3 were calculated.  
 
Results:  
10 LLSB patients who had lower urinary tract reconstruction and epidurals 
were matched to 10 LLSB patients who had lower urinary tract 
reconstruction and transverse abdominis plane blocks. Groups were 
demographically similar. All had full abdominal sensation and functional 
levels at or below L3. No epidural complications or changes in neurological 
status were noted. The epidural group had decreased opioid consumption 
on POD 0-3 (0.75 mg/kg vs. 1.29 mg/kg, p=0.04). Pain scores were similar or 
improved in the epidural group.  
 
Conclusions:  
Thoracic epidural analgesia appears to be a safe and effective opioid 
sparing option to assist with post-operative pain management following 
lower urinary tract reconstruction in LLSB patients.  
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Introduction: 
Treatment of post-operative pain has made significant advances due in part 
to the greater utilization of regional pain block techniques. Thoracic 
epidural anesthesia has been shown to be beneficial in the management of 
post-operative pain by decreasing respiratory complications, nausea and 
vomiting, time until return of bowel function, and hospital length of stay
1
. 
Although there are a few small case reports of epidural analgesia use in 
women with low level spina bifida (LLSB) during labor and delivery
2
, its use 
for post-operative pain management has never been studied.   
 
Concern of anatomical anomalies and worsening neurologic symptoms has 
prevented the utilization of epidural anesthesia in patients with neural tube 
defects
3
. Pre-existing neurological conditions, such as spina bifida (SB), 
might set the stage for a double-crush scenario, which maintains that 
patients with pre-existing neural compromise may be at increased 
susceptibility for subsequent nerve injury from a secondary insult
4
. This has 
historically led to recommendations not to perform regional anesthesia in 
this population
5
. Due to concern about their pain control and inspired by 
reports of success in case reports of epidural use in some patients during 
labor and delivery, we started placing epidurals in select patients with low 
level spina bifida. 
 
We sought to determine if patients who received epidurals suffered any 
complication related to the epidural or epidural placement. Our primary 
aim was to assess safety and secondary aim was to assess efficacy (by 
narcotic use and pain scores). We firstly hypothesize that thoracic epidural 
placement in the T9-T10 interspace in LLSB patients is safe, and patients 
would not be observed to have any motor or sensory changes due to the 
epidural placement. We further hypothesize decreased narcotic 
requirements in LLSB patients receiving an epidural compared to LLSB 
patients who underwent similar procedures without an epidural for 
perioperative pain relief.   
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Materials and Methods: 
Study Population 
Institutional Review Board approval was gained for the conduct of the 
study prior to retrospective data analysis. Neurosurgeons at our institution 
approved placement of thoracic epidural in select patients without 
evidence of thoracic disease (Figure 1). All patients with LLSB (functional 
lesion diagnosed by the developmental pediatrician based on motor 
function as L3 or below) undergoing LUTR with an MRI showing no 
evidence of thoracic disease were offered a thoracic epidural. LLSB patients 
without an MRI in our system were excluded and were not offered 
epidurals. Following surgery, physical therapy and occupational therapy 
worked with the patient and evaluated the patient’s neurological status 
daily as part of their care.  
 
Matching 
We retrospectively reviewed consecutive LLSB patients who had LUTR and 
received epidurals at our institution from April 2016 to October 2017. Due 
to the nature of lower urinary tract surgery, each patient had multiple 
procedures performed under one anesthetic. We performed a 
retrospective case control study and matched these patients to controls 
with LLSB based on similarity of procedures performed under the same 
anesthetic. Controls received single shot transversus abdominis plane (TAP) 
blocks, which were placed at the end of the procedure with ultrasound 
guidance. Prior to offering epidurals, TAP blocks were the current standard 
of care at our institution for such procedures. To most ideally select our 
control group based on procedures, controls were recruited from a wider 
time frame from December 2013 to October 2017. Operative time was 
used as a marker for complexity of the surgery performed and was 
measured as the time from surgery start to surgery stop. 
 
 
Epidural Placement and Pain Management Strategies 
All epidurals were placed in the T9-10 interspace (Figure 2) after the patient 
was intubated and sedated. Ropivacaine 0.2% was infused at a rate of 0.4 
mg/kg/hr in epidurals. This is in line with recommended standard pediatric 
epidural infusions
5
. No patients in either group were given pre-operative 
opioid sparing analgesics. Additional opioid-sparing analgesics were not 
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administered intraoperatively in patients who received epidurals. Based on 
clinical situation, surgeon preference and anesthesia preference, some 
patients who received TAP blocks also received ketorolac and/or ketamine. 
Patients in both groups received prn diazepam, oral acetaminophen, 
ketorolac and either IV narcotics or a patient-controlled analgesia (PCA) 
pump based on clinical situation, surgeon preference, and anesthesia 
preference post-operatively. No patients received gabapentin or ketamine 
following their procedure. PCA availability was recorded and defined as 
whether a PCA was offered to a patient. If the patient was not offered a 
PCA, prn IV narcotics were available for pain relief.  
 
Outcome Assessment 
Our primary outcome was to determine the safety of epidural placement in 
patients with LLSB undergoing bladder reconstruction. We defined safety as 
not experiencing changes in neurological status. Epidural complications 
were defined as asymmetric block, dural puncture, excessive block height, 
suboptimal analgesia, rapid onset block, spinal catheter migration, 
increased number of attempts/difficulty locating the epidural space, and 
post-procedural neurological deficit. For our secondary outcome, we 
evaluated the efficacy of the epidural by comparing opioid consumption 
and patient reported pain scores with and without an epidural on post-
operative days 0-3. Opioid consumption was calculated utilizing equivalent 
IV morphine doses. Nursing assessed pain scores 2 hours on a 0-10 scale. 
 
Statistical analysis 
Analysis involved Mann-Whitney U test for continuous data and Fisher’s 
exact tests for categorical data. A critical p≤0.05 was used (Stata 10.1 
StataCorp, College Station, TX, USA).  
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Results:  
A total of 10 LLSB patients who underwent LUTS had epidurals placed 
during the study period were matched to 10 controls with LLSB who 
underwent similar procedures and had TAP blocks placed. Characteristics of 
the two groups, including age, gender, BMI, functional status, procedures 
performed, operative time, return of bowel function, number of antiemetic 
doses taken, or length of stay were not significantly different between 
groups (Table 1). There was no difference in VP shunt status between 
groups (epidural 10 vs. control 6, p=0.09). Of note, all patients who 
received an epidural had a VP shunt.  
 
No epidural-related complications or changes in neurological status were 
observed. All patients in both groups had functional levels at or below L3 
and reported full abdominal sensation prior to surgery. This was unchanged 
following their procedure. 
 
The epidural group had decreased opioid consumption on POD 0-3 (0.75 
mg/kg vs. 1.29 mg/kg, p=0.04). Median mean and max pain scores were the 
same or improved in the epidural group (Table 1). Of note, no patient was 
diagnosed with any chronic pain condition or was taking opioid medication 
prior to their surgical procedure. 
 
There was no difference in post-operative complications not related to 
epidural placement between groups (p=0.33). In the epidural group, three 
Clavien 1 complications (all clostridium difficile colitis) and one Clavien 2 
complication (ileus requiring TPN) were observed. In the control group, two 
patients had complications. One patient developed clostridium difficile 
colitis (Clavien 1) and the other developed an ileus not requiring TPN and 
required a blood transfusion for a slowly declining hematocrit (Clavien 2)
6
. 
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Discussion: 
This study represents the first description and report of thoracic epidurals 
used for perioperative pain control in patients with LLSB. Most importantly, 
no patient in our cohort developed any change in their baseline 
neurological function such as motor or sensory changes as a result of 
epidural placement. No complication related to epidural placement was 
observed. Thoracic epidural analgesia appears safe in patients with VP 
shunts, as all patients in the epidural group had VP shunts. Additionally, 
those with an epidural were noted to require almost half the narcotics as 
those without epidurals, while reporting similar or improved pain scores. 
 
The use of epidural anesthesia in parturients with SB has been reported but 
is limited to anecdotal case reports
7-13 and small case series
14-17
. Most 
research has reported on outcomes of pregnant women with spina bifida 
during labor and delivery, with only one small case series describing 
epidural use for post-operative pain
18
. Overall, these series found epidural 
analgesia to be safe. Reported complications in the 52 reported epidurals 
included asymmetric block in 1 (1.9%)
14
, dural puncture in 3 (5.8%)
7,13,14
, 
excessive block height in 1 (1.9%)
14
, suboptimal analgesia in 7 (13.5%)
9,14
, 
rapid onset block in 1 (1.9%)
9
, spinal catheter migration in 1 (1.9%)
12
, 
increased number of attempts/difficulty locating the epidural space in 3 
(5.8%)
2,17
 and post-procedural neurological deficit in 1 (1.9%)
8
. There is a 
consensus, which was also supported by our study that if neuraxial 
analgesia is considered in patients with SB, the needle insertion should 
occur at a level above the vertebral abnormality
3,9
. 
 
There are several limitations to our study inherent to a retrospective cohort 
study. Firstly, we were unable to exactly match patients by procedure type 
given the individual complexity of each lower urinary tract reconstruction. 
However, we did match on bladder augmentation, bladder neck procedures 
and catheterizable bladder channel creation. Additionally, the opioid and 
non-opioid pain and adjunct medications offered were not uniform 
between patients due to clinical course, surgeon, or anesthesia preference. 
Finally, since this was a feasibility study, it was not adequately powered to 
evaluate for differences in other clinically relevant outcomes such as time 
to return of bowel function or hospital length of stay. 
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This study demonstrates the feasibility and potential benefits of thoracic 
epidurals used in carefully selected LLSB patients undergoing major 
abdominal surgery. Further research with a larger population is needed to 
corroborate and better evaluate other clinically relevant outcomes such as 
time to return of bowel function or hospital length of stay. Therefore, we 
are currently planning a prospective trial to further evaluate the safety and 
potential benefit of epidural anesthesia in this patient population.  
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Conclusions 
In appropriately selected LLSB patients, thoracic epidural analgesia appears 
to be a safe and effective option to assist with opioid sparing approaches to 
post-operative pain management. Pain scores are similar or lower in 
patients with epidurals compared to TAP blocks following LUTR. No 
epidural complications were noted. 
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Table 1: Patient Characteristics 
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Figure 1: Two representative MRIs of patients who had epidurals placed. 
Arrows indicate the location the epidural was placed and the boxes 
highlight the neural tube defect 
 
Figure 2: Two representative images of patients following epidural 
placement. Boxes highlight the scar from the closure of the neural tube 
defect 
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 Epidural 
Cohort (N=10) 
Control 
Cohort (N=10) 
p-value 
Age in years, median (IQR) 6.5 (5.3-7.8) 7 (9.5) 0.45 
Male patients, no. (%) 7 (70%) 4 (40%) 0.37 
BMI in kg/m
2
, median (IQR) 16.5 
(14.6-18.1) 
18.7 
(15.8-21.6) 
0.21 
Presence of VP Shunt 10 6 0.09 
    
Procedures Performed   0.97 
Enterocystoplasty 5 5 
Bladder Neck Sling 3 3 
Bladder Neck Reconstruction 1 2 
Malone antegrade continence 
enema 
5 8 
Catheterizable channel creation 7 9 
Operative Time in min, median (IQR) 385 
(292.5-466) 
308.5 
(228.5-409.5) 
0.19 
    
Functional Level   0.56 
L3, no. (%) 5 (50%) 3 (30%) 
L4, no. (%) 1 (10%) 3 (30%) 
L5, no. (%) 1 (10%) 2 (20%) 
S1, no. (%) 1 (10%) 0 (0%) 
S3, no. (%) 2 (20%) 3 (30%) 
    
Date of Epidural Removal    
POD2, no. (%) 1 (10%) -  
POD3, no. (%) 4 (50%) -  
POD4, no. (%) 4 (40.0%) -  
POD5, no. (%) 1 (10.0%) -  
    
PCA available to patient, no. (%) 4 (40%) 6 (60%) 0.66 
    
Total IV Morphine Requirements on 
POD 0-3 (mg/kg), median (IQR) 
0.75  
(0.50-1.05) 
1.29  
(0.91-1.87) 
0.04 
    
Pain Scores    
Mean POD #0, median (IQR) 1.70  
(1.06-2.5) 
2.91  
(2.05-3.65)  
0.06 
Max POD #0, median (IQR) 4.5 (3.0-5.75) 4.0 (4.0-5.0)  0.97 
Mean POD #1, median (IQR) 1.67  
(1.05-1.81) 
2.13  
(1.62-2.59)  
0.11 
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Max POD #1, median (IQR) 6.0 (4.25-6.0)  5.5 (5.0-6.0)  0.97 
Mean POD #2, median (IQR) 0.83  
(0.37-1.42) 
1.67 
(1.10-3.46) 
<0.05 
Max POD #2, median (IQR) 3.5 (2.25-4.0) 6.0 (5.0-6.0) 0.01 
Mean POD #3, median (IQR) 0.87  
(0.58-1.23) 
1.46  
(0.32-2.24) 
0.41 
Max POD #3, median (IQR) 4.0 (3.25-5) 4.0 (2.5-6.75) 0.85 
    
POD of Return of Bowel Function, 
median (IQR) 
4.0  
(3.25-4.75) 
5.0  
(4.0-5.75) 
0.26 
Antiemetics Taken on POD 0-3, median 
(IQR) 
0.0 (0.0-2.75) 1.0 (0.0-1.75) 0.99 
Length of Stay in Days, median (IQR) 7.0  
(7.0-8.5) 
6.0  
(5.25-7.75) 
0.27 
    
Post-Operative Complications   0.8 
Clavien grade 1 3 1 
Clavien grade 2 1 1 
Clavien grade 3 0 0 
Clavien grade 4 0 0 
Clavien grade 5 0 0 
Changes in neurological status 0 0 0.99 
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Abbreviations: LLSB: low level spina bifida, LUTR: lower urinary tract reconstruction, POD: post-
operative day, PCA: patient controlled analgesia, TAP: transversus abdominis plane 
 
 
